MAPT and Parkinson disease: Over the course of two years, CSF levels of α-syn, Tau proteins, NfL, and YKL-40 increased in patients with PD. α-syn and Tau levels, in particular, remain stable in the early phases of PD but increase as the disease progresses. It is suspected that α-syn levels will increase further with neurodegeneration over time.